Elevation Spine

Executive Summary

Elevation Spine, headquartered in Austin, Texas, is a privately held medical device company dedicated to advancing spinal fusion surgery. Founded in 2015, the company has developed its proprietary Saber technology, with the flagship product Saber-C—a zero-profile anterior cervical plate-interbody-fixation system. Saber-C is designed to simplify the surgical procedure through a less invasive approach, potentially reducing operative time and improving patient outcomes compared to traditional fusion devices. The technology aims to enhance surgical efficiency while maintaining stability and fusion success rates. Elevation Spine's innovation addresses a growing demand in the cervical fusion market, where surgeons seek streamlined solutions that minimize tissue disruption and implant profile. The global spinal fusion market is expanding, driven by an aging population and rising prevalence of degenerative disc disease. Elevation Spine's Saber-C targets a key segment of this market with a differentiated design that could offer competitive advantages in ease of use and clinical outcomes. However, as a private company with limited public disclosure, its regulatory pathway and commercial traction remain unclear. The company's ability to achieve regulatory clearance and secure adoption among spine surgeons will be critical to its success. If clinical data and user feedback validate the technology's benefits, Elevation Spine could become a notable player in the cervical fusion space.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for Saber-C70% success
• Q1 2027First-in-human clinical study enrollment60% success
• Q2 2027Key opinion leader endorsement or publication on Saber-C50% success